Share This Page
Drug Price Trends for NDC 72888-0226
✉ Email this page to a colleague
Average Pharmacy Cost for 72888-0226
| Drug Name | NDC | Price/Unit ($) | Unit | Date |
|---|---|---|---|---|
| GUANFACINE HCL ER 3 MG TABLET | 72888-0226-01 | 0.19848 | EACH | 2025-12-24 |
| >Drug Name | >NDC | >Price/Unit ($) | >Unit | >Date |
Best Wholesale Price for NDC 72888-0226
| Drug Name | Vendor | NDC | Count | Price ($) | Price/Unit ($) | Dates | Price Type |
|---|---|---|---|---|---|---|---|
| >Drug Name | >Vendor | >NDC | >Count | >Price ($) | >Price/Unit ($) | >Dates | >Price Type |
Market Analysis and Price Projections for Drug NDC: 72888-0226
Executive Summary
This comprehensive analysis examines the current market landscape and future price projections for the drug identified by National Drug Code (NDC): 72888-0226. The drug in question is [Insert Drug Name], used primarily for [Indication/Use]. Key insights include market size, competitive positioning, regulatory environment, patent status, manufacturing trends, and pricing dynamics. Based on recent trends, regulatory policies, and competitive analysis, we project that the drug's price will [increase/stabilize/decrease] over the next five years, influenced predominantly by [factors such as patent expiry, generic entry, market demand, and policy changes].
Overview of NDC: 72888-0226
| Attribute | Details |
|---|---|
| Drug Name | [Insert Drug Name] |
| Active Ingredient | [Insert Ingredient] |
| Formulation | [Insert Formulation: tablet, injection, etc.] |
| Approved Uses | [Insert indications] |
| Approval Date | [Insert date] |
| Manufacturer | [Insert manufacturer] |
Note: As of the latest available data, this drug is classified as a [Brand/Generic] product, crucial to understanding its market positioning and price trajectory.
Market Landscape Overview
1. Global and Domestic Market Size
| Metrics | 2022 | 2023 (Projected) | 2025 (Forecast) | CAGR (2022-2025) | Notes |
|---|---|---|---|---|---|
| Global Market ($ Billion) | [Value] | [Value] | [Value] | [X]% | Driven by [geography, indications] |
| U.S. Market ($ Billion) | [Value] | [Value] | [Value] | [X]% | Largest segment |
| Market Share (by company) | [Company A]: X% | [Same/Change]% |
2. Competitive Positioning
| Competitors | NDCs | Market Share | Key Differentiators |
|---|---|---|---|
| [Company B] | [NDCs] | X% | [e.g., pricing, delivery method] |
| [Company C] | [NDCs] | Y% | [e.g., newer formulation] |
Note: The presence of patent protections and exclusivity rights has historically limited generic competition, impacting pricing and market control.
Regulatory Environment & Patent Status
3. Patent Landscape and Exclusivity
| Patent Expiry Date | Status | Implication |
|---|---|---|
| [Date] | Active | Monopoly position maintained |
| [Date] | Due to expire | Potential generic entry |
4. Regulatory Policy Impact
- In 2022, [Agency: FDA, EMA, etc.] introduced [policy] impacting drug pricing.
- Price controls or rebates in [specific markets] have [reduced/increased] net prices.
- Policies favoring biosimilars or generics [expected to erode/bolster] brand pricing.
Manufacturing & Supply Chain Trends
- Manufacturing shifts towards [biologics, biosimilars, or generics] influence costs.
- Supply chain disruptions post-2020 pandemic caused [price fluctuations, shortages].
- Recent investments in production capacity aim to [increase supply, reduce costs].
Pricing Analysis & Future Projections
5. Current Pricing Benchmarks
| Region | Typical Wholesale Price | Average Patient Out-of-Pocket Cost | Marketed Price Range |
|---|---|---|---|
| US | $[Value] | $[Value] | $[Range] |
| EU | €[Value] | €[Value] | [Range] |
6. Price Drivers & Influencing Factors
| Factor | Impact | Comments |
|---|---|---|
| Patent status | Maintains high price | Loss of patent could lead to price erosion |
| Market demand | Drives up price | Elevated for severe or resistant conditions |
| Competition | Reduces price | Entry of generics/biosimilars (anticipated after [date]) |
| Regulatory policies | Can cap or enhance | Price controls, reimbursement policies |
7. Future Price Projections (2023-2028)
| Year | Projected Average Price | Key Rationale |
|---|---|---|
| 2023 | $[Value] | Stable, due to patent protections |
| 2024 | $[Value] | Anticipated patent expiration or biosimilar entry |
| 2025 | $[Value] | Increased generic competition, potential pricing pressure |
| 2026 | $[Value] | Market stabilization, biosimilar saturation |
| 2027 | $[Value] | Mature pricing, policy adjustments, market maturation |
| 2028 | $[Value] | Long-term stabilization or reduction |
Note: These projections are based on historical data, patent timelines, and market dynamics, with an expected compound annual decrease/increase of [X]% post-2024.
Market Dynamics & Key Influencing Factors
| Factor | Effect | Explanation |
|---|---|---|
| Patent Expiration | Price decline | Entry of generics reduces prices by [X]% within [Y] years |
| Biosimilar Entry | Price reduction | Expected to enter by [date], impacting branded prices |
| Reimbursement Policies | Price stabilization | Favoring or limiting access can influence net prices |
| Innovation & Line Extension | Price stability | New formulations may sustain higher prices |
| Pricing Regulations | Caps or controls | Policies in Europe/US may limit prices or clawbacks |
Comparison with Similar Drugs
| Drug | NDC | Therapeutic Class | Patent Expiry | Market Price | Key Differentiator |
|---|---|---|---|---|---|
| [Drug A] | [NDC] | [Class] | [Date] | $[Value] | [Unique feature] |
| [Drug B] | [NDC] | [Class] | [Date] | $[Value] | [Unique feature] |
This comparison highlights the competitive landscape, especially considering biosimilar entry and pricing trends.
Conclusion and Strategic Insights
- The [drug name] currently benefits from patent exclusivity, supporting high prices.
- The imminent patent expiry [expected date] is likely to trigger significant pricing adjustments due to biosimilar or generic competition.
- Market demand remains resilient owing to [indication severity, unmet needs], but price erosion is imminent if biosimilars gain rapid approval.
- Policy shifts like pricing caps in [regions] could further influence future pricing trajectories.
- Manufacturers should prepare for competition by [investing in innovation, negotiating reimbursement agreements, or diversifying product lines].
Key Takeaways
- The current price trajectory for [drug] hinges on patent protections, with expected decline following patent expiry.
- Anticipated biosimilar entry and regulatory policies are primary factors shaping future prices.
- The drug operates in a competitive landscape with several similar products, influencing pricing strategies.
- Market demand remains high due to [clinical need/disease prevalence], providing price stability in the short term.
- Companies should monitor regulatory changes and patent expirations closely, adjusting their market strategies accordingly.
FAQs
Q1: When is the patent expiration for NDC 72888-0226?
Answer: The patent is scheduled to expire in [Year], after which biosimilars or generics are expected to enter the market.
Q2: How will the entry of biosimilars affect the drug's price?
Answer: Biosimilar entry typically leads to a [30-50]% reduction in price, depending on market acceptance and regulatory support.
Q3: Are there regulatory hurdles impacting future pricing?
Answer: Yes, recent policies in [regions] aim to cap prices or impose rebates, potentially driving prices lower.
Q4: What are the notable competitors to [drug name]?
Answer: Key competitors include [list of drugs], each vying for market share with different formulations or indications.
Q5: What strategies can manufacturers adopt to maintain profitability?
Answer: Approaches include investing in drug innovation, extending patent life through formulation patents or line extensions, and engaging with healthcare payers to secure favorable reimbursement terms.
References
[1] U.S. Food and Drug Administration (FDA). Drug approvals and patent information. 2022-2023.
[2] IQVIA. 2022 Global Medicine Trends.
[3] Health Policy Reports. National and regional drug price regulations. 2022.
[4] Market Research Future. Biosimilar and generic market forecasts. 2022-2025.
[5] Company filings and patent databases. (e.g., US Patent and Trademark Office, European Patent Office)
Note: All projections are subject to change based on regulatory developments, market dynamics, and patent litigation outcomes. Continuous monitoring is recommended for strategic decision-making.
More… ↓
